TICKERNOMICS Sign up
Last Update: 2024-03-28 02:15:15
Axcella Health Inc. ( AXLA ) https://www.axcellahealth.com
0.40USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
-96.32%
AXLA
SPY
32.74%
-99.67%
AXLA
SPY
92.93%
AXLA
0.00%
SPY
224.41%
AXLA
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
29.54
22.44
0.01
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.59
0.00
-13.08
-54.67
0.00
-1.52
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
0.00
0.00
0.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.27
1786.07
-1124.32
0.00
Other Earnings and Cash Flow Stats:
Axcella Health Inc. ( AXLA ) Net Income TTM ($MM) is -68.25
Axcella Health Inc. ( AXLA ) Operating Income TTM ($MM) is -62.20
Axcella Health Inc. ( AXLA ) Owners' Earnings Annual ($MM) is 0.00
Axcella Health Inc. ( AXLA ) Current Price to Owners' Earnings ratio is 0.00
Axcella Health Inc. ( AXLA ) EBITDA TTM ($MM) is -61.89
Axcella Health Inc. ( AXLA ) EBITDA Margin is 0.00%
Capital Allocation:
Axcella Health Inc. ( AXLA ) has paid 0.00 dividends per share and bought back -19.332789 million shares in the past 12 months
Axcella Health Inc. ( AXLA ) has reduced its debt by 0.376 million USD in the last 12 months
Capital Structure:
Axcella Health Inc. ( AXLA ) Interest-bearing Debt ($MM) as of last quarter is 1
Axcella Health Inc. ( AXLA ) Annual Working Capital Investments ($MM) are 22
Axcella Health Inc. ( AXLA ) Book Value ($MM) as of last quarter is -3
Axcella Health Inc. ( AXLA ) Debt/Capital as of last quarter is 245%
Other Balance Sheet Stats:
Axcella Health Inc. ( AXLA ) has 8 million in cash on hand as of last quarter
Axcella Health Inc. ( AXLA ) has 11 million of liabilities due within 12 months, and long term debt 0 as of last quarter
Axcella Health Inc. ( AXLA ) has 73 common shares outstanding as of last quarter
Axcella Health Inc. ( AXLA ) has 0 million USD of preferred stock value
Academic Scores:
Axcella Health Inc. ( AXLA ) Altman Z-Score is -68.25 as of last quarter
Axcella Health Inc. ( AXLA ) Piotroski Score is 1.00 as of last quarter
Corporate Governance:
Axcella Health Inc. ( AXLA ) largest shareholder is UBS Group AG owning 106 shares at 0.00 ($MM) value
Margaret Koziel(an insider) Sold 27 shares of Axcella Health Inc. ( AXLA ) for the amount of $391.50 on 2023-03-01
15.80% of Axcella Health Inc. ( AXLA ) is held by insiders, and 55.80% is held by institutions
Axcella Health Inc. ( AXLA ) went public on 2019-05-09
Other Axcella Health Inc. ( AXLA ) financial metrics:
FCF:-56.66
Unlevered Free Cash Flow:-36.69
EPS:-0.19
Operating Margin:0.00
Gross Profit Margin:0.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:604.61
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Axcella Health Inc. ( AXLA ) :
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.